 Jillian Cotter
Concepts (255)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Community-Acquired Infections | 10 | 2025 | 169 | 4.470 |
Why?
| | Pneumonia | 13 | 2024 | 631 | 3.830 |
Why?
| | Hospitals, Pediatric | 15 | 2025 | 533 | 2.390 |
Why?
| | Anti-Bacterial Agents | 12 | 2025 | 1790 | 1.890 |
Why?
| | Clostridium Infections | 2 | 2024 | 70 | 1.420 |
Why?
| | Respiratory Tract Infections | 6 | 2025 | 395 | 1.230 |
Why?
| | Length of Stay | 7 | 2024 | 1203 | 1.130 |
Why?
| | Feces | 3 | 2023 | 477 | 1.130 |
Why?
| | Child | 41 | 2025 | 21896 | 1.010 |
Why?
| | Communicable Diseases | 3 | 2023 | 160 | 0.910 |
Why?
| | Gastroenteritis | 2 | 2023 | 68 | 0.870 |
Why?
| | Soft Tissue Infections | 2 | 2021 | 37 | 0.850 |
Why?
| | Multicenter Studies as Topic | 1 | 2025 | 303 | 0.850 |
Why?
| | Multiplex Polymerase Chain Reaction | 2 | 2021 | 54 | 0.840 |
Why?
| | Diagnostic Tests, Routine | 1 | 2024 | 109 | 0.810 |
Why?
| | Urinary Tract Infections | 2 | 2024 | 166 | 0.800 |
Why?
| | Antimicrobial Stewardship | 2 | 2021 | 114 | 0.750 |
Why?
| | Asthma | 4 | 2024 | 2285 | 0.720 |
Why?
| | Pneumonia, Bacterial | 1 | 2022 | 117 | 0.720 |
Why?
| | Retrospective Studies | 24 | 2025 | 15514 | 0.710 |
Why?
| | Respiratory Insufficiency | 1 | 2024 | 316 | 0.670 |
Why?
| | Cholangitis, Sclerosing | 2 | 2018 | 75 | 0.660 |
Why?
| | Diarrhea | 2 | 2023 | 182 | 0.660 |
Why?
| | Dexamethasone | 2 | 2019 | 374 | 0.660 |
Why?
| | Fecal Microbiota Transplantation | 1 | 2019 | 23 | 0.650 |
Why?
| | Infant | 19 | 2025 | 9408 | 0.640 |
Why?
| | Prednisone | 2 | 2019 | 239 | 0.620 |
Why?
| | Administration, Intravenous | 3 | 2024 | 152 | 0.590 |
Why?
| | Liver Function Tests | 2 | 2018 | 114 | 0.590 |
Why?
| | Patient Care | 1 | 2019 | 110 | 0.590 |
Why?
| | Research Design | 1 | 2025 | 1108 | 0.590 |
Why?
| | Child, Preschool | 16 | 2025 | 11013 | 0.590 |
Why?
| | Child, Hospitalized | 3 | 2024 | 53 | 0.590 |
Why?
| | Pediatricians | 1 | 2019 | 131 | 0.570 |
Why?
| | Gastrointestinal Diseases | 1 | 2020 | 208 | 0.560 |
Why?
| | Humans | 55 | 2025 | 136899 | 0.490 |
Why?
| | Hospitalization | 9 | 2025 | 2183 | 0.490 |
Why?
| | Patient Readmission | 5 | 2024 | 693 | 0.480 |
Why?
| | Liver Cirrhosis | 1 | 2018 | 316 | 0.480 |
Why?
| | Education, Medical, Graduate | 1 | 2019 | 476 | 0.460 |
Why?
| | Practice Patterns, Physicians' | 2 | 2025 | 1310 | 0.460 |
Why?
| | Propensity Score | 3 | 2024 | 287 | 0.420 |
Why?
| | Administration, Oral | 2 | 2024 | 811 | 0.370 |
Why?
| | Adolescent | 12 | 2025 | 21402 | 0.340 |
Why?
| | Prospective Studies | 8 | 2023 | 7543 | 0.340 |
Why?
| | Emergency Service, Hospital | 8 | 2025 | 2033 | 0.340 |
Why?
| | Intervertebral Disc Degeneration | 2 | 2014 | 33 | 0.310 |
Why?
| | Cross-Sectional Studies | 8 | 2025 | 5398 | 0.310 |
Why?
| | Male | 20 | 2025 | 67308 | 0.300 |
Why?
| | Patient Safety | 2 | 2019 | 305 | 0.250 |
Why?
| | Female | 18 | 2025 | 72703 | 0.250 |
Why?
| | Influenza, Human | 2 | 2023 | 626 | 0.240 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2025 | 48 | 0.230 |
Why?
| | Amoxicillin | 1 | 2025 | 30 | 0.230 |
Why?
| | Antigens, Bacterial | 1 | 2025 | 129 | 0.230 |
Why?
| | Transforming Growth Factor beta3 | 1 | 2014 | 10 | 0.220 |
Why?
| | Diskectomy | 1 | 2014 | 23 | 0.220 |
Why?
| | Thrombocythemia, Essential | 1 | 2014 | 7 | 0.220 |
Why?
| | Tennis | 1 | 2014 | 5 | 0.220 |
Why?
| | Polycythemia Vera | 1 | 2014 | 12 | 0.220 |
Why?
| | Primary Myelofibrosis | 1 | 2014 | 10 | 0.220 |
Why?
| | Ascorbic Acid Deficiency | 1 | 2024 | 8 | 0.220 |
Why?
| | Phlebotomy | 1 | 2024 | 21 | 0.220 |
Why?
| | Scurvy | 1 | 2024 | 15 | 0.220 |
Why?
| | Cannula | 1 | 2024 | 22 | 0.220 |
Why?
| | Intervertebral Disc | 1 | 2014 | 39 | 0.210 |
Why?
| | Cell Survival | 2 | 2014 | 1122 | 0.210 |
Why?
| | Hospitals, Community | 1 | 2024 | 50 | 0.210 |
Why?
| | Streptococcus pneumoniae | 1 | 2025 | 169 | 0.210 |
Why?
| | Treatment Failure | 1 | 2024 | 353 | 0.210 |
Why?
| | Matrix Attachment Region Binding Proteins | 1 | 2013 | 7 | 0.210 |
Why?
| | Hypertension, Portal | 1 | 2014 | 64 | 0.210 |
Why?
| | Critical Pathways | 1 | 2024 | 89 | 0.200 |
Why?
| | Spinal Fractures | 1 | 2014 | 84 | 0.200 |
Why?
| | Portal Vein | 1 | 2014 | 117 | 0.200 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2023 | 75 | 0.190 |
Why?
| | Seizures, Febrile | 1 | 2022 | 21 | 0.190 |
Why?
| | Low Back Pain | 1 | 2014 | 106 | 0.190 |
Why?
| | Curriculum | 2 | 2019 | 978 | 0.190 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2024 | 160 | 0.190 |
Why?
| | Viruses | 1 | 2023 | 111 | 0.190 |
Why?
| | Femur Neck | 1 | 2012 | 63 | 0.190 |
Why?
| | Lumbar Vertebrae | 1 | 2014 | 245 | 0.190 |
Why?
| | Data Collection | 1 | 2025 | 674 | 0.190 |
Why?
| | Respiratory Syncytial Virus Infections | 1 | 2023 | 127 | 0.190 |
Why?
| | Clinical Competence | 2 | 2019 | 1086 | 0.190 |
Why?
| | Treatment Outcome | 5 | 2024 | 10768 | 0.180 |
Why?
| | Intracranial Aneurysm | 2 | 2008 | 97 | 0.180 |
Why?
| | Fever | 1 | 2022 | 307 | 0.180 |
Why?
| | Hospital Medicine | 1 | 2022 | 90 | 0.180 |
Why?
| | Virus Diseases | 1 | 2023 | 216 | 0.170 |
Why?
| | Aftercare | 1 | 2022 | 210 | 0.170 |
Why?
| | Skin Diseases, Infectious | 1 | 2020 | 16 | 0.170 |
Why?
| | Pseudomonas Infections | 1 | 2022 | 224 | 0.170 |
Why?
| | Endpoint Determination | 1 | 2020 | 77 | 0.170 |
Why?
| | Mentoring | 1 | 2022 | 144 | 0.160 |
Why?
| | Blood Culture | 1 | 2020 | 23 | 0.160 |
Why?
| | Hematopoietic Stem Cells | 1 | 2013 | 398 | 0.160 |
Why?
| | Severity of Illness Index | 4 | 2022 | 2833 | 0.160 |
Why?
| | Pulmonologists | 1 | 2019 | 15 | 0.160 |
Why?
| | Mandatory Reporting | 1 | 2019 | 45 | 0.160 |
Why?
| | Bone and Bones | 1 | 2012 | 317 | 0.160 |
Why?
| | Symptom Flare Up | 1 | 2019 | 40 | 0.160 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2022 | 232 | 0.160 |
Why?
| | Rotator Cuff Injuries | 1 | 2019 | 60 | 0.160 |
Why?
| | Respiration, Artificial | 1 | 2024 | 643 | 0.160 |
Why?
| | Drug Substitution | 1 | 2019 | 55 | 0.150 |
Why?
| | Competency-Based Education | 1 | 2019 | 74 | 0.150 |
Why?
| | Biliary Tract | 1 | 2018 | 17 | 0.140 |
Why?
| | Immunocompromised Host | 1 | 2019 | 203 | 0.140 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 1 | 2018 | 23 | 0.140 |
Why?
| | Arthroscopy | 1 | 2019 | 217 | 0.140 |
Why?
| | Infant, Newborn | 3 | 2024 | 6043 | 0.140 |
Why?
| | Otitis Media | 1 | 2020 | 165 | 0.140 |
Why?
| | Time-to-Treatment | 1 | 2019 | 200 | 0.140 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 784 | 0.130 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2008 | 1242 | 0.130 |
Why?
| | Polymerase Chain Reaction | 1 | 2020 | 1061 | 0.130 |
Why?
| | Universities | 1 | 2019 | 431 | 0.130 |
Why?
| | Pandemics | 2 | 2023 | 1615 | 0.130 |
Why?
| | Patient Discharge | 1 | 2022 | 887 | 0.130 |
Why?
| | Sepsis | 1 | 2022 | 610 | 0.130 |
Why?
| | Consensus | 1 | 2019 | 678 | 0.120 |
Why?
| | Preleukemia | 1 | 2015 | 2 | 0.120 |
Why?
| | Incidence | 2 | 2020 | 2783 | 0.120 |
Why?
| | Colorado | 3 | 2020 | 4491 | 0.120 |
Why?
| | Anti-Inflammatory Agents | 1 | 2019 | 498 | 0.120 |
Why?
| | Hospitalists | 1 | 2019 | 243 | 0.120 |
Why?
| | Schools | 1 | 2018 | 463 | 0.120 |
Why?
| | Self Report | 1 | 2019 | 827 | 0.110 |
Why?
| | Quality of Life | 2 | 2023 | 2847 | 0.110 |
Why?
| | Communication | 1 | 2019 | 872 | 0.100 |
Why?
| | Lumbosacral Region | 1 | 2013 | 58 | 0.100 |
Why?
| | Prevalence | 1 | 2020 | 2709 | 0.100 |
Why?
| | Trans-Activators | 1 | 2015 | 399 | 0.100 |
Why?
| | Cystic Fibrosis | 1 | 2022 | 1088 | 0.100 |
Why?
| | Medical Errors | 1 | 2013 | 110 | 0.100 |
Why?
| | Intraoperative Complications | 1 | 2013 | 140 | 0.100 |
Why?
| | Internship and Residency | 2 | 2019 | 1131 | 0.100 |
Why?
| | Polymorphism, Genetic | 2 | 2013 | 652 | 0.100 |
Why?
| | Proto-Oncogene Proteins | 1 | 2015 | 646 | 0.090 |
Why?
| | Gastrointestinal Microbiome | 1 | 2019 | 689 | 0.090 |
Why?
| | Spine | 1 | 2013 | 174 | 0.090 |
Why?
| | Age Factors | 1 | 2019 | 3290 | 0.090 |
Why?
| | Inflammation | 2 | 2008 | 2817 | 0.090 |
Why?
| | Pediatrics | 1 | 2018 | 1119 | 0.080 |
Why?
| | United States | 5 | 2025 | 14595 | 0.080 |
Why?
| | Surveys and Questionnaires | 2 | 2019 | 5730 | 0.080 |
Why?
| | Liver Transplantation | 1 | 2017 | 870 | 0.080 |
Why?
| | Liver | 1 | 2018 | 1937 | 0.080 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2015 | 620 | 0.080 |
Why?
| | Primary Health Care | 1 | 2018 | 1741 | 0.070 |
Why?
| | Postoperative Complications | 1 | 2019 | 2627 | 0.070 |
Why?
| | Biomarkers | 1 | 2018 | 4148 | 0.060 |
Why?
| | Serogroup | 1 | 2025 | 44 | 0.060 |
Why?
| | Disease Progression | 3 | 2019 | 2744 | 0.060 |
Why?
| | Inflammation Mediators | 1 | 2008 | 514 | 0.060 |
Why?
| | Aggrecans | 1 | 2014 | 14 | 0.060 |
Why?
| | Genetic Predisposition to Disease | 1 | 2013 | 2416 | 0.050 |
Why?
| | Organ Culture Techniques | 1 | 2014 | 156 | 0.050 |
Why?
| | Proteoglycans | 1 | 2014 | 107 | 0.050 |
Why?
| | Fracture Healing | 1 | 2014 | 82 | 0.050 |
Why?
| | Penicillins | 1 | 2023 | 59 | 0.050 |
Why?
| | Uncertainty | 1 | 2024 | 125 | 0.050 |
Why?
| | Ascorbic Acid | 1 | 2024 | 123 | 0.050 |
Why?
| | Patient Acuity | 1 | 2022 | 45 | 0.050 |
Why?
| | Microbial Sensitivity Tests | 1 | 2024 | 362 | 0.050 |
Why?
| | Bone Development | 1 | 2012 | 54 | 0.050 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2013 | 106 | 0.050 |
Why?
| | Tensile Strength | 1 | 2012 | 97 | 0.050 |
Why?
| | Cell Polarity | 1 | 2013 | 141 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2013 | 138 | 0.050 |
Why?
| | Cattle | 1 | 2014 | 982 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 2 | 2024 | 3710 | 0.050 |
Why?
| | Goals | 1 | 2022 | 168 | 0.050 |
Why?
| | Cell Lineage | 1 | 2013 | 346 | 0.040 |
Why?
| | Cadaver | 1 | 2012 | 318 | 0.040 |
Why?
| | Outpatients | 1 | 2024 | 393 | 0.040 |
Why?
| | Social Determinants of Health | 1 | 2024 | 246 | 0.040 |
Why?
| | Mentors | 1 | 2022 | 192 | 0.040 |
Why?
| | Benchmarking | 1 | 2022 | 184 | 0.040 |
Why?
| | Peer Group | 1 | 2022 | 244 | 0.040 |
Why?
| | ROC Curve | 1 | 2022 | 543 | 0.040 |
Why?
| | Ambulatory Care | 1 | 2024 | 528 | 0.040 |
Why?
| | Medicaid | 1 | 2024 | 433 | 0.040 |
Why?
| | Stress, Mechanical | 1 | 2012 | 475 | 0.040 |
Why?
| | Absenteeism | 1 | 2020 | 49 | 0.040 |
Why?
| | Regression Analysis | 1 | 2012 | 1026 | 0.040 |
Why?
| | Pseudomonas aeruginosa | 1 | 2022 | 353 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2023 | 552 | 0.040 |
Why?
| | Guideline Adherence | 1 | 2023 | 544 | 0.040 |
Why?
| | Biomechanical Phenomena | 1 | 2012 | 765 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2013 | 599 | 0.040 |
Why?
| | Hospitals | 1 | 2024 | 678 | 0.040 |
Why?
| | Nitric Oxide | 1 | 2014 | 914 | 0.040 |
Why?
| | Bone Density | 1 | 2012 | 486 | 0.040 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2013 | 854 | 0.040 |
Why?
| | Anti-Infective Agents | 1 | 2020 | 255 | 0.040 |
Why?
| | Adult | 4 | 2019 | 37595 | 0.030 |
Why?
| | Shoulder Joint | 1 | 2019 | 171 | 0.030 |
Why?
| | Bacteremia | 1 | 2020 | 209 | 0.030 |
Why?
| | Chronic Disease | 1 | 2023 | 1773 | 0.030 |
Why?
| | Clinical Protocols | 1 | 2019 | 268 | 0.030 |
Why?
| | Range of Motion, Articular | 1 | 2019 | 387 | 0.030 |
Why?
| | Acute Disease | 1 | 2020 | 1000 | 0.030 |
Why?
| | Japan | 1 | 2017 | 116 | 0.030 |
Why?
| | Biopsy, Needle | 1 | 2017 | 191 | 0.030 |
Why?
| | Animals | 4 | 2015 | 36915 | 0.030 |
Why?
| | Internationality | 1 | 2017 | 155 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2013 | 1167 | 0.030 |
Why?
| | Teaching | 1 | 2018 | 224 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2013 | 2998 | 0.030 |
Why?
| | Inpatients | 1 | 2020 | 497 | 0.030 |
Why?
| | Recovery of Function | 1 | 2019 | 657 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2017 | 690 | 0.030 |
Why?
| | Blotting, Northern | 1 | 2005 | 199 | 0.030 |
Why?
| | Fatty Acid Desaturases | 1 | 2005 | 32 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2013 | 4204 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2013 | 1976 | 0.030 |
Why?
| | Arabidopsis Proteins | 1 | 2005 | 73 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2017 | 1324 | 0.030 |
Why?
| | Survival Analysis | 1 | 2017 | 1320 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2017 | 1262 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2670 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2014 | 4281 | 0.030 |
Why?
| | Middle Aged | 3 | 2019 | 33118 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1524 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 974 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2017 | 1739 | 0.020 |
Why?
| | Blotting, Western | 1 | 2005 | 1227 | 0.020 |
Why?
| | Mice | 2 | 2015 | 17775 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2013 | 5766 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 2030 | 0.020 |
Why?
| | Neurosurgical Procedures | 1 | 2013 | 199 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2013 | 565 | 0.020 |
Why?
| | Aged | 2 | 2019 | 23641 | 0.020 |
Why?
| | Orthopedics | 1 | 2013 | 151 | 0.020 |
Why?
| | Risk | 1 | 2013 | 905 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2012 | 7552 | 0.020 |
Why?
| | Internet | 1 | 2013 | 652 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 5126 | 0.020 |
Why?
| | Genotype | 1 | 2013 | 1906 | 0.020 |
Why?
| | Rupture | 1 | 2008 | 93 | 0.020 |
Why?
| | Risk Assessment | 1 | 2017 | 3432 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2005 | 2837 | 0.020 |
Why?
| | Cohort Studies | 1 | 2017 | 5711 | 0.020 |
Why?
| | Risk Factors | 2 | 2013 | 10313 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2008 | 509 | 0.010 |
Why?
| | Hemodynamics | 1 | 2008 | 1114 | 0.010 |
Why?
| | Sex Factors | 1 | 2008 | 2067 | 0.010 |
Why?
| | Proteins | 1 | 2008 | 1012 | 0.010 |
Why?
| | Endothelium, Vascular | 1 | 2008 | 922 | 0.010 |
Why?
| | Smoking | 1 | 2008 | 1633 | 0.010 |
Why?
| | Apoptosis | 1 | 2008 | 2542 | 0.010 |
Why?
| | Hypertension | 1 | 2008 | 1291 | 0.010 |
Why?
|
|
Cotter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|